Neuronetics Insider Sales Reveal Tax Moves, Not Confidence Worries
Neuronetics insider selling: CFO’s tax‑related RSU exit, CEO and EVP trades, but buying continues—insiders stay confident in the biotech’s future.
3 minutes to read
Neuronetics Inc
Insider Buying Fuels Confidence in Neuronetics’ NeuroStar TMS Platform
Insider buying boosts confidence in Neuronetics’ NeuroStar TMS device, showing strong efficacy for depression, low risk, and FDA expansion into OCD.
4 minutes to read
Insider Buy at Neuronetics Signals Confidence Amid Volatility
Insider buying of Neuronetics shares at $1.16 signals confidence amid a 73 % decline—why Jorey’s purchase may hint at undervaluation and future upside.
3 minutes to read
Insider Sales at Neuronetics: Routine Tax Moves, Not a Red‑Flag for Investors
Insider sales at Neuronetics show routine tax‑planning, not distress, amid steady cash flow and neutral market sentiment.
5 minutes to read
Neuronetics Insider Selling: CEO’s $1.65 Sale Reveals Tax Strategy, Not Market Fear
Neuronetics insider sales reveal tax‑driven moves, not a bearish signal—CEO keeps 15 % stake while market volatility rises.
3 minutes to read
Neuronetics Insider Sales: Tax‑Driven Moves, Market Outlook, and Investor Takeaways
Insider sales at Neuronetics are routine tax moves, not a sign of doubt—yet investors must watch future trades, reimbursement deals and tech progress for hidden risks.
4 minutes to read